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Abstract
The human fundus is a complex structure that can be easily visualized and the world of ophthalmology is going through a golden era of new and 
exciting fundus imaging techniques; recent advances in technology have allowed a significant improvement in the imaging modalities clinicians 
have available to formulate a diagnostic and treatment plan for the patient, but there is constant on-going work to improve current technology 
and create new ideas in order to gather as much information as possible from the human fundus. In this article we shall summarize the imaging 
techniques available in the standard medical retina clinic (i.e. not limited to the research lab) and delineate the technologies that we believe will 
have a significant impact on the way clinicians will assess retinal and choroidal pathology in the not too distant future.
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Introduction
‘In the whole history of Medicine there is no more beautiful episode 
than the invention of the ophthalmoscope’1 is how the introduction into 
clinical practice of this fundamental instrument was greeted. The invention 
of the ophthalmoscope by von Helmholtz in 1851 triggered a cascade of 
other innovations and data analysis tools that has led to an increasingly 
accurate assessment of patients with retinal disease. In the twenty-first 
century  amongst other techniques, ophthalmologists have access to a 
vast array of equipment and technology to image the fundus including 
the slit-lamp, fundus cameras, fundus fluorescein angiography (FFA), 
indocyanine green angiography (ICG), fundus autofluorescence (FAF), 
optical coherence tomography (OCT). Furthermore, this technology is 
constantly being updated as new instruments are designed.
In this article, the authors will summarize the techniques currently 
available in the standard clinical setting to image the human fundus 
and investigate the use of other exciting imaging modalities that 
are appearing on the horizon of the medical retina clinic and which 
the authors believe are destined to increase the ophthalmologist’s 
diagnostic armamentarium. 
Background
The ocular fundus is a complex multi-layered structure2 that can be 
analyzed by several techniques: when light strikes the fundus, it can 
be reflected, absorbed, scattered, transmitted, or remitted, depending on 
the wavelength of incident light and tissue histology: image formation 
is determined by the amount of each wavelength reflected. Structural 
changes will cause localized variations in light/tissue interaction, with 
consequent variations in the amount of light reflected, and this will affect 
some wavelengths more than others, sometimes with specific patterns 
depending on the pathology in question.
The first published photographs of in-vivo human retina used a camera 
fixed to the subject’s head and a 2.5 minute exposure.3 Since then, 
major advances have been made in fundus imaging, including short 
exposure photography without movement artefacts and high resolution 
real-time digital color fundus photography, which produce high quality 
fundus images, nowadays frequently taken for granted. In addition, 
FFA and ICG, that have become part of the routine practice in the 
medical retina clinics, allow dynamic investigation of the retinal and 
choroidal circulation.
The rapid advances in computer technology and the digital photography 
revolution have directly led to techniques like OCT and FAF, which are 
deepening our understanding of retinal/choroidal pathology.
The Present
Color Fundus Photography
Three wavelength (red-green-blue or RGB) fundus photography provides 
the basis for color fundus photography, which has an important role in the 
diagnosis and monitoring of retinal conditions. For diabetic retinopathy 
photography, the standard technique for many years has been the seven 
field (stereo) technique, which still forms the gold-standard of disease 
monitoring in clinical trials.4
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However, the difficult and time consuming nature of this technique 
for patients and staff makes it impractical for large-scale population 
screening of diabetic retinopathy. The EURODIAB IDDM complications 
study therefore validated the method of using two fundus photographs, 
centred on the optic disc and macula respectively5; this has now formed 
the basis for the English National Diabetic Retinopathy Screening 
Programme,6 which offers annual digital fundus photographic screening 
of all persons with diabetes in England. The scheme uses remote grading 
of fundus photographs and has built in extensive quality controls to 
ensure safety and cost-effectiveness.
Fundus Fluorescein Angiography and  
Indocyanine Green Angiography
Fundus fluorescein angiography and ICG are dynamic investigations of the 
fundus circulations in the retina and choroid and have provided entirely 
new insights into the pathophysiology of fundus diseases. Both techniques 
rely on the fact that fluorescein and indocyanine green dyes, once they 
have absorbed a specific exciting wavelength (465–90 nm and 790–805 nm 
respectively), remit a different wavelength (520–30 nm and 825–35 nm) that 
can be photographed by a fundus camera fitted with appropriate filters.7-9 
In the case of FFA this is light in the yellow-green part of the spectrum, 
whist for ICG the fluorescence is in the non-visible, infrared area of 
the spectrum.
Fundus Autofluorescence
Autofluorescence is the ability of a substance to absorb light of a particular 
wavelength and emit a longer wavelength, without any additional dyes. 
This phenomenon is classically seen in cases of optic disc drusen,10 
photographed with a fluorescein angiography camera but without 
fluorescein dye being injected.  Autofluorecscence in the retinal pigment 
epithelium (RPE) has been known for many years from histological 
studies,11,12 however the use of in vivo FAF measurement is relatively 
recent.13,14 FAF is mainly due to lipofuscin granules in the RPE,15 which 
are a manifestation of the viability of cell metabolism; excessive FAF can 
be a consequence of a ‘sick’ RPE, incapable of clearing all the lipofuscin 
present, or accumulation of excessive amounts of lipofuscin production; 
reduced FAF, which appears dark or even black on FAF imaging, is 
usually an indication of severe loss of the RPE.16 Detection of FAF can be 
obtained either with a confocal scanning laser ophthalmoscope17 or with 
a modified fundus camera18 and numerous studies have demonstrated 
the usefulness of FAF imaging in the assessment of subjects with loss of 
vision and the presence of distinctive patterns of FAF change in certain 
fundus disorders.16,19-28 
The use of FAF has also been expanded by using dual wavelength 
autofluorescence, a technique pioneered by Delori and especially useful 
in the measurement of macular pigment optical density.29,30
Optical Coherence Tomography
Optical Coherence Tomography (OCT) provides a cross sectional analysis 
of the fundus (optical biopsy),31,32 and has heralded a new era in retinal 
imaging. In recent years the full potential of this technique is beginning 
to be appreciated, to a point that new classifications and descriptions of 
pathologies are being introduced based on OCT findings. Time domain 
OCTs have been replaced by the higher quality spectral domain (SD -) 
OCTs33 that allow resolution to around 5–10 microns and are much faster 
thereby reducing motion artefacts and improving patient compliance.34,35 
In figure 1, a case of acute macular neuroretinopathy (AMN) is shown: the 
characteristic petalloid abnormalities are evident on the fundus image 
generated by infrared wavelengths, with corresponding disturbance  of 
the inner segment-outer segment junction on the OCT (arrow heads); the 
localization on OCT of the structural abnormalities in the outer retina has 
prompted some authors to rename this condition acute macular outer 
retinopathy (AMOR).36
From a clinical perspective, SD-OCT has become a valuable tool in the 
diagnosis and monitoring of retinal conditions and has become a major 
part of the assessment of retinal morphology and treatment decision 
in the management of neovascular age-related macular degeneration 
(AMD), diabetic macular oedema and retinal vein occlusions.
Ultra-high resolution OCT has now also been developed,37,38 and it is likely 
that improved resolution in future OCT machines will permit resolution at 
the level of individual photoreceptors.39 However whether this improved 
resolution will prove to be clinically useful remains to be seen. It is also 
important to realize the limitations of current OCT and to remember 
that OCT does not replace careful fundus examination. An example of 
this is the detection of small points of subretinal hemorrhage on fundus 
examination, which is a crucial finding in patients undergoing treatment 
with anti-VEGF agents , as it might warrant further treatment but may be 
invisible on OCT alone. 
A further application of SD-OCT is enhanced depth imaging (EDI), a method 
to obtain better quality images of the choroid and evaluate its thickness.40,41 
We are now beginning to better understand the functions of the choroid 
and it is evident it contributes to the metabolic integrity of the retinal 
pigment epithelium and of the retina, acts as a ‘dark room’ by absorbing 
excess light reaching the retina, partly supplies blood to the pre-laminar 
portion of the optic nerve, and is thought to act as a ‘heat sink’, allowing 
dissipation of thermal energy produced by the high metabolic rate of the 
retinal structures.2,38,42-46 Any pathology affecting the choroid will therefore 
also alter the metabolism of the retina, RPE and optic nerve. Therefore 
imaging and evaluation of the choroid is likely to be increasingly important 
as we look to understand fundus pathology.47-51 Modern equipment has 
inbuilt modules to automatically obtain EDI; however with older machines, 
Figure 1: Young Subject with Acute Macular  
Neuroretinopathy. The Arrow Heads Indicate  
Disturbance of the Inner-Outer Segment Junction
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equivalent measurements can be made by simply positioning the 
equipment close enough to the eye to obtain an inverted fundus image40 
(100 averaged scans gives the best quality cross-sections).
Wide-field Fundus Photography
Several pathologies affect primarily the fundus periphery and 
a full retinal assessment can only be carried out by indirect 
ophthalmoscopy and scleral depression, which are time-consuming 
and frequently uncomfortable for the patient. Retinal ischemia is best 
characterized with fluorescein angiography; traditional FFA employs 
retinal photography able to view approximately 30° of the retina at 
one time. The Early Treatment Diabetic Retinopathy Study (ETDRS) 
developed the seven-standard fields (7SF) protocol in which seven 
photographed areas of the retina were combined to give nearly 75° 
of visualization.4 
With the advent of ultra-widefield fluorescein angiography (UWFFA),52-54 
it is possible to image up to 200° of retina (see Figure 2); furthermore 
the Optos cameras (Optos PLC, Dunfermline) incorporate low-powered 
laser wavelengths in the green and red parts of the spectrum, allowing 
visualization from the neurosensory retina to beyond the RPE, into 
the choroid.
Initial small-scale studies have shown that UWFFA is useful in detecting 
capillary non-perfusion in patients with diabetic retinopathy, both 
proliferative and with diabetic macular oedema, which is better than other 
methods with a more limited degree of retinal imaging.55
Ultra-widefield fluorescein angiography opens up the possibility of 
targeting laser photocoagulation to areas of capillary closure which 
might be more effective and less damaging than conventional pan-retinal 
laser photocoagulation. 
It must be remembered however that wide-field fundus imaging has 
limitations and it cannot, at present, replace indirect ophthalmoscopy with 
scleral indentation for detecting peripheral retinal breaks; furthermore, at 
present it is not advocated for diabetic retinopathy screening.  
However continuing refinement of this technology means that wide field 
fundus imaging is likely to play an increasingly important role in the eye 
clinic of the future.
The Future
In this section, the authors tackle several techniques they believe will 
eventually make their way into routine clinical practice.
Retinal Oximetry
Retinal oximetry56–58 is based on the spectroscopic measurement of blood 
within the retinal vessels and it exploits the different spectral characteristics 
of oxygenated (HbO2) versus deoxygenated hemoglobin (Hb). In this way, 
it has been used to plot out oxygenation maps of the fundus and correlate 
this in different retino-vascular pathologies.59 Hypoxia is believed to play a 
fundamental role in several retinal pathologies:  it is not surprising therefore 
that the possibility to measure retinal oxygenation has been increasingly 
popular in the ophthalmology research world.60-81 There are numerous 
techniques currently under investigation to establish the best suited for 
clinical practice and it is highly likely that a tool to this scope will make its 
way into the standard retinal clinics in the not too distant future.
Retro-mode imaging
The F-10 (Nidek, Japan) is a confocal scanning laser ophthalmoscope 
(SLO) which non-invasively scans the fundus with a Class 1 laser.  Different 
modes of imaging include reflectance modes for various wavelengths 
Figure 2: Wide-Field Fundus Fluorescein and 
Indocyanin Green Angiography of Subject with 
Placoid Lesions  
(Courtesy of Mr Sergio Pagliarini, Coventry, UK).
Figure 3: Autofluorescence Decay Time (left column) 
and Intensity (right column) of Normal (A and B) and 
Age-Related Macular Degeneration (C and D) Subject.
(Courtesy of Professor Dietrich, Department of Ophthalmology, 
University of Jena, Germany) 
24/10/2011
FA&ICGA 5:25.87 30˚ ART 6:4290 30˚
A
C D
B
Red indicates more, blue indicates less.
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(490nm, 532  nm, 660  nm and 790  nm), fluorescein angiography, 
indocyanine green angiography and a novel technique, retro-mode.
Retro-mode imaging uses an infrared laser (wavelength 790  nm) and 
employs an aperture with a modified central stop, which is deviated 
laterally from the confocal light path, and may be positioned to the left or 
right side of the fundus.  The scattered light passing through the deviated 
aperture gives a shadow to features such as subretinal deposits thus 
enhancing the contrast and delineation of these features. (see Figure 3) 
Retro-mode images have demonstrated that they are an extremely 
sensitive means of monitoring retinal drusen and can measure size 
changes over small time periods. This technique may prove to be a useful 
means of monitoring retinal drusen in cases of AMD and evaluate future 
interventional therapies.82
Time-based autofluorescence and Functional 
Optical Coherence Tomography
Pathology affects metabolism before structural changes occur83 and 
at this early stage of disease, alterations are usually still reversible. 
It is believed substances like FAD, NADH, lipofuscin, collagen, 
elastin, and glycation end products are of fundamental importance 
in metabolic processes of disease;84 all these substances are 
considered fluorophores, i.e. substances that emit some form of 
spectral radiation when exposed to light, and each is characterized 
by a specific absorption spectrum, emission spectrum and life-time 
of the fluorescence (fluorescence decay time) once stimulated; this 
last characteristic is of particular interest, as each fluorophore has 
a specific fluorescence decay time, which is not influenced by the 
concentration of the fluorophore itself nor the surrounding tissue;83-87 
therefore different fluorophores can be differentiated as those emitting 
with the same fluorescence can be discriminated from each other by 
fluorescence intensity and decay time. 
In Figure 4 (courtesy of Professor Dietrich Schweitzer) a comparison 
between time-based autofluorescence of a healthy individual (a and b) 
and a subject with AMD (c and d) is demonstrated. In the left column, the 
lifetimes of autofluorescence in picoseconds are featured, whereas the 
left column is an indication of autofluorescence intensity. It is evident that 
the intensity and decay time of autofluorescence are different between 
the two. 
By combining measurements of the fluorescence decay time with optical 
coherence tomography, it should be possible to generate a ‘functional 
OCT’. Time and spectrally resolved measurements of autofluorescence 
have the potential to monitor metabolism at the cellular level; it will be 
possible to assess functionality of single retinal layers or of different 
retinal areas, possibly paving the way to localized treatment: for example, 
in the context of diabetic retinopathy, it may be possible to identify, 
non-invasively, areas of the retina that will eventually trigger new vessel 
formation due to hypo-perfusion (which causes abnormal metabolism), 
allowing localized laser photocoagulation to be applied only in that 
specific area, before the new vessels develop. 
Adaptive Optics
The resolution of current fundus imaging equipment is mainly limited by 
the optical aberrations within the eye.39,88,89 One of the most promising 
Figure 4: Retro–Mode Fundus Image of Patient’s 
Left Eye with Retinal Drusen, Showing the  
Preudo-3D Effect that Enhances Drusen Detection.
507nm 525nm
585nm552nm
596nm 611nm
Figure 5: Set of Multispectral Fundus Images of 
Individual with Drusen and Scarring from  
Choroidal Neovascular Membrane.
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advances in this field is adaptive optics (AO),39,90-94 a technique developed in 
astronomy to remove the effect of atmospheric turbulence from telescope 
images, that has also been adapted to be used in the human eye. One 
application has been to obtain high resolution images of the retina, in 
ultra-high resolution OCT machines, allowing the resolution of individual 
photoreceptors and other retinal cells in vivo.39,92,94,95 This may translate to 
widespread clinical use in a number of macular disorders such as AMD, 
where early intervention is crucial. 
The combination of AO with optical coherence tomography (OCT) has 
permitted cones to be resolved in vivo in great detail39 and the concept of 
individual cone imaging is now realistic. Whether this will lead to better and 
earlier treatments remains to be seen.
Multispectral Fundus Imaging
Light/tissue interaction is governed by tissue histology and wavelength 
of incident light; therefore the distribution, quantities and characteristic 
optical absorption properties of the fundus pigments and the spectral 
properties of the light used to illuminate the fundus will determine 
its appearance during fundoscopy/fundus imaging. It is therefore 
theoretically possible to recover tissue histology from images, providing 
the optical properties of each tissue component and the optical spectrum 
of the light source are known.
Conventional red-green-blue (RGB) digital images give good spatial 
resolution, but low spectral resolution, thus making truly accurate histological 
interpretation of the tissue practically impossible. On the other hand, 
traditional tissue spectroscopy allows a detailed characterization of a single 
point, but large areas of tissue cannot be examined.
Multispectral imaging combines the advantages of both techniques, 
allowing detailed spectral analysis of a large area; this is achieved by 
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